Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Progesterone may help trans women with breast development and health, but more research is needed.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Spironolactone reduces hair growth in women with unexplained excessive hairiness.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Steroid hormones can help treat aging issues and improve health in elderly people.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

High doses of ethynylestradiol in rats caused growth issues, organ changes, and some tumors, but didn't increase overall tumor rates.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.